Healthcare Technology
Ataraxis AI is a clinical AI research lab developing multi-modal AI methods to predict patient outcomes and treatment response in precision medicine. The company creates AI tools that help physicians select optimal treatments, with research spanning causality analysis (Ataraxis™ Tau), foundation models for digital pathology (Falcon and Kestrel), and survival analysis. Their first clinical product, Ataraxis™ Breast, assists in breast cancer treatment selection and is deployed across academic institutions and community clinics worldwide. The company is backed by prominent venture capital firms including Thiel Capital/Founders Fund and Obvious Ventures, with advisors including AI pioneer Yann LeCun and distinguished oncologists from top cancer research institutions.
Beta · Sourced from candidate reports
Be the first to share your experience with Ataraxis AI.
Your reply helps other candidates know what to expect.
